Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 8/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.69 |
| ▸ | RAB9A | P51151 | 6/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.69 |
| ▸ | HPGD | P15428 | 5/20 | 0.69 |
| ▸ | TP53 | P04637 | 5/20 | 0.69 |
| ▸ | MAPT | P10636 | 5/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.69 |
| ▸ | MEN1 | O00255 | 3/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.69 |
| ▸ | PKM | P14618 | 3/20 | 0.69 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.69 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.69 |
| ▸ | ATM | Q13315 | 1/20 | 0.67 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.67 |
| ▸ | GAA | P10253 | 2/20 | 0.58 |
| ▸ | GLA | P06280 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29531707 | 1.00 | NPC1 (0.69) | NPC1ALDH1A1RAB9AHSD17B10HPGD | |
| SCHEMBL29504749 | 0.91 | TOP2A (0.62) | NPC1ALDH1A1RAB9AHSD17B10HPGD | |
| Anthracene SCHEMBL29003509 | 0.91 | NPC1 (0.66) | NPC1ALDH1A1RAB9AHSD17B10HPGD | |
| SCHEMBL171055 | 0.91 | TOP2A (0.62) | NPC1ALDH1A1RAB9AHSD17B10HPGD | |
| SCHEMBL21674121 | 0.91 | NPC1 (0.63) | NPC1ALDH1A1RAB9AHSD17B10HPGD | |
| SCHEMBL31170 | 0.91 | NPC1 (0.81) | NPC1ALDH1A1RAB9AHSD17B10HPGD | |
| SCHEMBL23079834 | 0.89 | NPC1 (0.61) | NPC1ALDH1A1RAB9AHSD17B10HPGD | |
| SCHEMBL17562381 | 0.89 | ALOX5 (0.67) | NPC1ALDH1A1RAB9AHSD17B10HPGD | |
| SCHEMBL31476 | 0.89 | NPC1 (0.79) | NPC1ALDH1A1RAB9AHSD17B10HPGD | |
| SCHEMBL12854009 | 0.89 | TOP2A (0.60) | NPC1ALDH1A1RAB9AHSD17B10HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8142863-B2 | Color liquid crystal display and compensation panel | Crysoptix, KK (JP) | 2012-03-27 | — | — | US | claimed |
| EP-2291703-A2 | COLOR LIQUID CRYSTAL DISPLAY AND COMPENSATION PANEL | CRYSOPTIX K.K. (JP) | 2011-03-09 | — | — | EP | claimed |
| US-20100279122-A1 | Benzimidazole, Benzoxazole and Benzothiazole Derivatives, Optical Film Comprising them and Method of Producing thereof | CRYSOPTIX KK (JP) | 2010-11-04 | — | — | US | claimed |
| US-7659026-B2 | membrane electrodes; electrocatalysts; fuel cells | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-02-09 | — | — | US | claimed |
| US-20090268136-A1 | Color Liquid Crystal Display and Compensation Panel | CRYSOPTIX KK (JP) | 2009-10-29 | — | — | US | claimed |
| WO-2009130676-A2 | COLOR LIQUID CRYSTAL DISPLAY AND COMPENSATION PANEL | CRYSOPTIX KK (JP) | 2009-10-29 | — | — | WO | claimed |
| EP-2081913-A2 | BENZIMIDAZOLE,BENZOXAZOLE AND BENZOTHIAZOLE DERIVATIVES, OPTICAL FILM COMPRISING THEM AND METHOD OF PRODUCTION THEREOF | CRYSOPTIX K.K. (JP) | 2009-07-29 | — | — | EP | claimed |
| WO-2008020211-A2 | BENZIMIDAZOLE, BENZOXAZOLE AND BENZOTHIAZOLE DERIVATIVES, OPTICAL FILM COMPRISING THEM AND METHOD OF PRODUCTION THEREOF | CRYSOPTIX K.K. (JP) | 2008-02-21 | — | — | WO | claimed |
| JP-2007528843-A | — | — | 2007-10-18 | — | — | JP | claimed |
| US-20060178411-A1 | Sulfonimide containing compounds and their use in polymer electrolyte membranes for electrochemical cells | E. I. DU PONT DE NEMOURS AND COMPANY | 2006-08-10 | — | — | US | claimed |
| US-20060177717-A1 | Fluorinated sulfonamide compounds and polymer electrolyte membranes prepared therefrom for use in electrochemical cells | U.S. DEPARTMENT OF ENERGY | 2006-08-10 | — | — | US | claimed |
| WO-2005003081-A2 | SULFONIMIDE CONTAINING COMPOUNDS AND THEIR USE IN POLYMER ELECTROLYTE MEMBRANES FOR ELECTROCHEMICAL CELLS | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2005-01-13 | — | — | WO | claimed |
| WO-2005001979-A2 | FLUORINATED SULFONAMIDE COMPOUNDS AND POLYMER ELECTROLYTE MEMBRANES PEPARED THEREFROM FOR USE IN ELECTROCHEMICAL CELLS | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2005-01-06 | — | — | WO | claimed |
| US-5571874-A | AZOLE POLYMER, THIAZOLE RING CLOSURE, POLYAMIDE MATRIX | HONDA GIKEN KOGYO KABUSHIKI KAISHA (JP) | 1996-11-05 | — | — | US | claimed |
| US-4142037-A | USEFUL IN AEROSPACE APPLICATIONS SUCH AS SEALS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 1979-02-27 | — | — | US | claimed |
| CN-219215607-U | Full-automatic filling and tail sealing machine for bifonazole cream | 武汉润欣科技股份有限公司 | 2023-06-20 | — | — | CN | disclosed |
| CN-115974805-A | Anthracene compound | 烟台显华化工科技有限公司 | 2023-04-18 | — | — | CN | disclosed |
| US-4115367-A | ELASTOMERS, THERMAL AND HYDROLYTIC STABILITY | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 1978-09-19 | — | — | US | disclosed |
| US-4064109-A | SEALS, SEALANTS, THERMOOXIDATIVE AND HYDROLYTIC STABILITY | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 1977-12-20 | — | — | US | disclosed |
| US-4053498-A | PERFLUOROALKYLENE ETHER-IMIDATE AND -THIOIMIDATE ESTERS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 1977-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060178411-A1 | Sulfonimide containing compounds and their use in polymer electrolyte membranes for electrochemical cells | HCN2, KCNN2, NHERF1 | NPC1 1092/4885ALDH1A1 3591/4885RAB9A 442/4885 |
| US-20060177717-A1 | Fluorinated sulfonamide compounds and polymer electrolyte membranes prepared therefrom for use in electrochemical cells | PEF1, NHERF1, PXMP4 | NPC1 741/4885ALDH1A1 3230/4885RAB9A 1865/4885 |
| US-20100279122-A1 | Benzimidazole, Benzoxazole and Benzothiazole Derivatives, Optical Film Comprising them and Method of Producing thereof | BMX, ABCG2, BRI3BP | NPC1 3022/4885ALDH1A1 1696/4885RAB9A 2720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.